Rosacea Isn't One Thing — and That's Why Your 'Anti-Redness' Routine Isn't Working
Flushing, bumps, and visible vessels are three different problems hiding under one word, and treating them the same way is how most people make their skin angrier.
This was one of the few teledermatology-prescribed azelaic acid formulations that combined prescription-strength 15% azelaic acid with 4% niacinamide in a single compounded cream. The pairing of these two actives in one step streamlined routines for acne and hyperpigmentation without requiring separate products for each concern.
A well-formulated prescription azelaic acid cream that paired two proven actives in one step for acne, rosacea, and hyperpigmentation. The teledermatology convenience came at a premium, and the brand's sudden shutdown in 2025 left patients scrambling — but the formula itself was genuinely effective for those who used it.
Because Apostrophe was a teledermatology platform that shut down in March 2025, public feedback is capped at the roughly 350 reviews gathered during its 2019–2025 run. The 15% azelaic acid active is heavily studied, but this particular compounded cream was never reviewed widely outside the platform, so the score rests mostly on formulation analysis.
The case for it
Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Same rule for everyone. “Strong choice” is the verdict on 1,459 of 45,024 concern verdicts across the catalog; rule R2 decided 892 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
Also listed for Rough Texture and Dullness — the actives here (Azelaic Acid, Niacinamide, Aloe Vera, Vitamin E) are in our research queue for those concerns; there is no verdict until their evidence rows are written. That is a gap in our table, not a mark against the product.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
There is a particular kind of frustration that comes with finding a skincare product that genuinely works for you, only to have it yanked away. For the patients who relied on Apostrophe's Azelaic Acid 15% cream, March 2025 delivered exactly that gut punch when Hims & Hers — the parent company that had acquired Apostrophe for a cool $190 million in 2021 — decided to shutter the entire platform to focus on its booming weight loss business. The prescription skincare equivalent of your favorite restaurant closing to become a juice bar.
But before the obituary, the formula itself deserves its due. Apostrophe's Azelaic Acid 15% was a compounded prescription cream that combined two dermatological heavyweights: azelaic acid at full prescription strength and niacinamide at a clinically relevant 4%. The pairing was smart. Azelaic acid does the heavy lifting — killing acne-causing bacteria, normalizing the rate at which skin cells shed inside pores, and inhibiting tyrosinase to fade dark spots. Niacinamide reinforces from the flanks, calming inflammation, reducing sebum production, and strengthening the moisture barrier so the azelaic acid can do its work without leaving the skin compromised.
The vehicle was deliberately minimal. Aloe vera juice as the primary soothing agent, caprylic/capric triglycerides for a touch of emollience, tocopheryl acetate for antioxidant backup, and phenoxyethanol as the sole preservative. No fragrance, no unnecessary botanical extracts, no Instagram-friendly but dermatologically questionable additions. This was a formula designed by dermatologists who wanted their patients to use it consistently without their skin throwing a fit.
Application was straightforward. The white cream dispensed from an airless pump — a thoughtful packaging choice that prevented contamination and ensured consistent dosing. It spread easily without dragging and absorbed within about a minute, leaving behind a matte, barely-there finish that layered well under moisturizer and sunscreen. The initial tingling that most azelaic acid users experience was present but manageable, typically subsiding within the first two weeks of use.
Where this product truly earned its following was in the combination of conditions it could address simultaneously. A patient dealing with hormonal acne along the jawline and lingering dark spots from previous breakouts could treat both with a single product, applied once or twice daily. Someone with mild rosacea and occasional breakouts found that the dual anti-inflammatory action of azelaic acid and niacinamide calmed both concerns without the irritation that retinoids or benzoyl peroxide might trigger. And critically, this was one of the few prescription-strength options safe for use during pregnancy — a gap that few other actives could fill.
The clinical evidence supporting 15% azelaic acid is robust and spans decades. Studies have demonstrated comparable efficacy to adapalene 0.1% for acne with significantly less irritation, meaningful improvements in papulopustular rosacea rivaling metronidazole, and measurable lightening of post-inflammatory hyperpigmentation. The addition of niacinamide at 4% was not merely trendy; multiple controlled trials have shown niacinamide's ability to reduce sebum excretion, improve skin barrier function, and provide its own independent brightening effect through inhibition of melanosome transfer.
The limitations were real, however. Azelaic acid at any concentration is not a fast worker. Users expecting the rapid visible peeling of a retinoid or the overnight bacterial knockout of benzoyl peroxide found azelaic acid's gradual, steady approach frustrating. Eight to twelve weeks for meaningful acne improvement, potentially sixteen or more for significant pigmentation fading — that is a long time to wait, especially when you are paying a subscription premium for the privilege.
And the cost was the elephant in the room. Apostrophe's teledermatology model — consultation fee plus ongoing prescription costs — placed this compounded cream at a significant markup over what a patient might pay for generic azelaic acid gel through traditional channels with insurance. The convenience of skipping the dermatologist's office was genuine, but convenience has always been an expensive luxury in healthcare.
The texture and user experience, while pleasant, were nothing remarkable. This was a workmanlike cream that did its job without fanfare. It did not have the elegant sensory profile of a Korean beauty serum or the satisfying slip of a high-end treatment. It was clinical in the best and most literal sense — effective, unembellished, and focused entirely on outcomes.
For the patients who found their rhythm with this product — who had navigated the initial tingling, waited through the slow weeks, and finally arrived at clearer, more even-toned skin — the brand's closure was a genuine loss. The good news is that azelaic acid at 15% is available through other channels, and the niacinamide can easily be added as a separate step. The formula was excellent, but the ingredients are not proprietary. What Apostrophe provided was the combination and the convenience, and while both are replaceable, the sudden disappearance reminded patients that in DTC healthcare, your prescription is only as stable as the parent company's quarterly earnings call.
The hero actives that drive this product's performance.
| Ingredient | Function | Evidence |
|---|---|---|
| Azelaic Acid (15%) | The cornerstone active at prescription strength, working as both a tyrosinase inhibitor to fade post-inflammatory hyperpigmentation and an antimicrobial that reduces Cutibacterium acnes proliferation. At 15%, it also normalizes keratinization to prevent pore clogging, complemented by the niacinamide for enhanced brightening. | Regulator-approved for Rosacea · well-established certainty |
| Niacinamide (4%) | Supports the azelaic acid by strengthening the skin barrier through increased ceramide production, while independently reducing sebum output and calming inflammation. The 4% concentration is optimized to enhance the azelaic acid's anti-redness effects without competing for absorption. | Emerging for Hyperpigmentation |
| Aloe Barbadensis Leaf Juice | Serves as the soothing counterbalance to the azelaic acid's potential for initial tingling, providing anti-inflammatory polysaccharides that help the skin adjust to the active without excessive irritation during the break-in period. | Not yet assessed |
| Tocopheryl Acetate | A stabilized form of vitamin E that provides antioxidant protection to the formulation while supporting the skin barrier repair that the azelaic acid and niacinamide initiate, helping to reduce oxidative stress in inflamed acne-prone skin. | Not yet assessed |
Ingredient standings describe the active at treatment-level doses and vehicles; this product's own condition grades weigh its actual formula.
Active Ingredients: Azelaic Acid (15%), Niacinamide (4%). Inactive Ingredients: Aloe Barbadensis Leaf Juice, C13-14 Isoparaffin, Caprylic/Capric Triglyceride, Water, Laureth-7, Phenoxyethanol, Polyacrylamide, Tocopheryl Acetate, Triethylene Glycol.
treatment
AM & PM
Apply a thin layer after cleansing and toning but before moisturizer. Can be used twice daily but many dermatologists recommend starting once daily in the evening to assess tolerance. Wait 1-2 minutes before layering moisturizer.
Mild tingling or warmth on initial application is normal and typically resolves within 2-4 weeks. Early improvements in skin texture and reduced redness may appear at 2-4 weeks. Significant acne clearing and pigmentation fading typically require 8-12 weeks of consistent use. Maximum results for melasma and post-inflammatory hyperpigmentation may take 16-24 weeks.
Azelaic acid at 15% concentration is among the most versatile prescription actives in dermatology, supported by decades of clinical evidence. A 2023 systematic review by King et al. published in the Journal of Cosmetic Dermatology evaluated azelaic acid's efficacy across acne, rosacea, melasma, and skin aging, concluding that 15-20% concentrations produced clinically meaningful improvements across all four indications with a favorable safety profile.
For acne specifically, azelaic acid works through a triple mechanism: antimicrobial activity against Cutibacterium acnes, normalization of follicular keratinization (preventing the clogged pores that initiate breakouts), and anti-inflammatory effects that reduce the redness and swelling of active lesions. A comparative study demonstrated that azelaic acid 15% gel achieved acne lesion reduction comparable to adapalene 0.1% gel over nine months, with significantly lower irritation scores — a meaningful advantage for patients who cannot tolerate retinoids.
The combination with niacinamide at 4% in this formulation is pharmacologically rational. Niacinamide independently reduces sebum production by modulating lipid synthesis in sebocytes, strengthens the skin barrier through increased ceramide production, and inhibits melanosome transfer from melanocytes to keratinocytes — providing a complementary brightening mechanism to azelaic acid's direct tyrosinase inhibition. While no published trial has evaluated this specific Apostrophe formulation, the individual actives at these concentrations each have robust evidence supporting their efficacy.
For rosacea, multiple randomized controlled trials have established 15% azelaic acid as a first-line treatment for papulopustular subtype, with efficacy comparable to or exceeding metronidazole 0.75% gel. A 2024 study published in the Journal of Dermatological Treatment confirmed that azelaic acid 15% significantly reduced post-acne hyperpigmentation indices and melanin content compared to vehicle control, reinforcing the ingredient's dual utility for both active lesions and their aftermath.
Dermatologists have long valued azelaic acid as a versatile and well-tolerated treatment option, particularly for patients who cannot use retinoids due to pregnancy, breastfeeding, or sensitivity concerns. Working dermatologists often find that 15% azelaic acid occupies a unique therapeutic niche — it addresses acne, rosacea, and hyperpigmentation simultaneously, which few other single actives can claim. The combination with niacinamide at 4% in this formulation aligns with evidence-based dermatological practice, as both ingredients have complementary mechanisms of action. Dermatologists commonly advise starting with once-daily evening application and titrating to twice daily as tolerance builds. The pregnancy safety profile makes this category of product especially valuable in clinical practice, where the overlap between hormonal acne and family planning is common.
Cleanse face with a gentle, pH-balanced cleanser and pat dry. Apply a pea-sized amount of the cream in a thin, even layer across the affected areas. Allow 1-2 minutes for absorption before applying moisturizer. Start with once-daily application in the evening for the first 2 weeks to assess tolerance, then increase to twice daily (morning and evening) if no significant irritation occurs. Always follow with broad-spectrum sunscreen SPF 30 or higher during the day. Avoid applying to broken skin, and discontinue temporarily if significant peeling or burning occurs.
Apostrophe's pricing model was the product's most significant drawback. The teledermatology consultation fee plus ongoing prescription costs placed this compounded cream well above what patients might pay for FDA-approved azelaic acid products like Finacea through traditional dermatology with insurance. For uninsured patients, the convenience of at-home consultation and doorstep delivery had genuine value, but the per-month cost was difficult to justify when generic azelaic acid prescriptions exist. The single 30 g size with no larger options meant no economies of scale for long-term users. With the brand now discontinued, the value proposition is moot — but it serves as a reminder that convenience-based healthcare pricing does not always align with ingredient quality.
This product was ideal for anyone dealing with acne, rosacea, or post-inflammatory hyperpigmentation who wanted a prescription-strength solution without the irritation of retinoids. It was especially valuable for pregnant or breastfeeding individuals seeking safe, effective acne treatment.
Those with very tight budgets had better options through traditional prescriptions with insurance. Anyone needing rapid visible results would find the slow onset frustrating compared to retinoids or benzoyl peroxide. With the brand now discontinued, everyone must look elsewhere.
Ready to try Apostrophe Azelaic Acid 15%?
Buy at Amazon ♥Lightweight white cream with a smooth, non-greasy consistency that spreads easily and absorbs within a minute
Essentially unscented with a very faint clinical/pharmaceutical note
30 g white pump bottle with Apostrophe branding, airless pump design for hygienic dispensing
Expect mild tingling or a warm sensation for the first 1-2 weeks, which is completely normal with azelaic acid at prescription strength. The cream applies smoothly and doesn't leave a white cast. Most users report the tingling subsides as the skin acclimates. Some initial dryness may occur if used twice daily from the start.
2-3 months with once to twice daily facial application
All Year
Apostrophe built its reputation on making prescription-strength actives accessible through teledermatology, bypassing traditional dermatologist wait times. This azelaic acid formula became popular among patients seeking a pregnancy-safe alternative to retinoids for acne and pigmentation. The brand was acquired by Hims & Hers in 2021 for $190 million, but was abruptly shut down in March 2025 as the parent company shifted focus to weight loss offerings.
Apostrophe launched in 2019 as a rebrand of YoDerm (founded 2012), a teledermatology platform connecting patients with board-certified dermatologists who prescribed customized compounded formulations. The brand was acquired by Hims & Hers for $190 million in 2021 and was shut down in March 2025.
Azelaic acid is too weak to treat real acne — you need benzoyl peroxide or retinoids.
Clinical trials show 15% azelaic acid achieves comparable acne reduction to adapalene 0.1% with significantly less irritation. It works through multiple mechanisms including antimicrobial activity and keratolysis.
Prescription azelaic acid from teledermatology platforms is the same as pharmacy-compounded generics.
Apostrophe's formulation was specifically compounded with niacinamide 4% and aloe vera as a vehicle, which differs from generic azelaic acid gels like Finacea that use different inactive ingredients and lack the niacinamide boost.
No. Apostrophe was shut down by its parent company Hims & Hers in March 2025. Patients who were using this formula were advised to transfer their prescriptions to other providers. Similar azelaic acid 15% formulations are available through other teledermatology platforms and as branded products like Finacea.
Yes — azelaic acid is classified as Category B for pregnancy and is one of the few prescription-strength acne treatments considered safe during pregnancy and breastfeeding. This Apostrophe formulation's niacinamide is also pregnancy-safe, making the entire formula suitable for expectant mothers dealing with hormonal acne.
With this formulation's 15% azelaic acid and 4% niacinamide combination, early improvements in skin texture and redness typically appear within 2-4 weeks. Significant acne clearing usually requires 8-12 weeks, and meaningful fading of post-inflammatory hyperpigmentation can take 16-24 weeks of consistent use.
Yes, and many dermatologists recommend this combination. Azelaic acid and retinoids work through different mechanisms and can complement each other. Apostrophe even offered combination formulations with tretinoin and azelaic acid together. When using separately, apply them at different times of day to minimize irritation.
Mild purging is possible in the first 2-4 weeks as azelaic acid's keratolytic action brings existing microcomedones to the surface faster. This is usually less severe than purging from retinoids. The niacinamide in this Apostrophe formula helps mitigate inflammation during any adjustment period.
Finacea (azelaic acid 15% gel) is the most widely available branded prescription alternative. Other teledermatology platforms like Curology and Dermatica also offer custom azelaic acid formulations. For OTC options, The Ordinary Azelaic Acid Suspension 10% provides a lower concentration without a prescription.
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
Effective for stubborn acne and post-acne marks
Gentle enough for sensitive skin
Noticeable texture improvement within weeks
Pregnancy-safe prescription option
Tingling and warmth on initial application
Subscription pricing felt expensive
Slower results compared to tretinoin for acne
Brand was abruptly discontinued